PE33396A1 - Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar - Google Patents
Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumarInfo
- Publication number
- PE33396A1 PE33396A1 PE1995272088A PE27208895A PE33396A1 PE 33396 A1 PE33396 A1 PE 33396A1 PE 1995272088 A PE1995272088 A PE 1995272088A PE 27208895 A PE27208895 A PE 27208895A PE 33396 A1 PE33396 A1 PE 33396A1
- Authority
- PE
- Peru
- Prior art keywords
- nicotine
- composition
- ansia
- smoking
- symptoms
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 3
- 229960002715 nicotine Drugs 0.000 title abstract 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000391 smoking effect Effects 0.000 title 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 229960001948 caffeine Drugs 0.000 abstract 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000004909 Moisturizer Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000001333 moisturizer Effects 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 239000012266 salt solution Substances 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26426294A | 1994-06-23 | 1994-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE33396A1 true PE33396A1 (es) | 1996-08-19 |
Family
ID=23005260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1995272088A PE33396A1 (es) | 1994-06-23 | 1995-06-22 | Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar |
Country Status (6)
| Country | Link |
|---|---|
| AU (1) | AU2703695A (fr) |
| IL (1) | IL114129A0 (fr) |
| MA (1) | MA23588A1 (fr) |
| PE (1) | PE33396A1 (fr) |
| WO (1) | WO1996000071A1 (fr) |
| ZA (1) | ZA955032B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO108596A0 (en) * | 1996-07-18 | 1996-08-08 | Collier, Gregory | Treatment of obesity |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| WO2003057188A1 (fr) | 2001-11-21 | 2003-07-17 | Alexza Molecular Delivery Corporation | Delivrance de cafeine par voie inhalee |
| WO2004104493A2 (fr) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Procede de regulation thermique uniforme d'un substrat ; unite de chauffage integree et unite d'administration de medicaments recourant a ce procede |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| CA2576961A1 (fr) | 2004-08-12 | 2006-03-02 | Alexza Pharmaceuticals, Inc. | Dispositif de distribution de drogue par aerosol integrant des conditionnements thermiques actionnes par percussion |
| EP2121088B1 (fr) | 2007-03-09 | 2016-07-13 | Alexza Pharmaceuticals, Inc. | Unité chauffante à utiliser dans un dispositif d'administration de médicament |
| US20110053988A1 (en) * | 2009-08-29 | 2011-03-03 | Jorge Alberto Cassara | Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke |
| DE102011114094A1 (de) * | 2011-09-21 | 2013-03-21 | F. Holzer Gmbh | Stimulierendes und belebendes Nasenspray und Nasentropfen |
| BR122023020807A2 (pt) | 2016-04-12 | 2023-12-12 | Arturo Solis Herrera | Uso de agonistas do receptor de acetilcolina nicotínica no tratamento de uma condição de uma membrana mucosa nasal ou paranasal |
| WO2019152873A1 (fr) | 2018-02-02 | 2019-08-08 | Alexza Pharmaceuticals, Inc. | Dispositif aérosol à condensation électrique |
| WO2019200427A1 (fr) | 2018-04-16 | 2019-10-24 | Barista Mist Pty Ltd | Compositions de caféine et procédés d'utilisation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4778677A (en) * | 1981-07-09 | 1988-10-18 | Ebbesen Gerald K | Method for treatment of nicotine craving |
| US4568676A (en) * | 1983-11-25 | 1986-02-04 | Thomas Jefferson University | Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor |
| DE3506406A1 (de) * | 1985-02-23 | 1986-08-28 | Hans-Josef 5600 Wuppertal Stromberg | Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten |
| US5051426A (en) * | 1990-03-27 | 1991-09-24 | Parnell Pharmaceuticals, Inc. | Method for effecting withdrawal from drug dependency |
-
1995
- 1995-05-16 MA MA23931A patent/MA23588A1/fr unknown
- 1995-06-09 WO PCT/US1995/007425 patent/WO1996000071A1/fr not_active Ceased
- 1995-06-09 AU AU27036/95A patent/AU2703695A/en not_active Abandoned
- 1995-06-13 IL IL11412995A patent/IL114129A0/xx unknown
- 1995-06-19 ZA ZA955032A patent/ZA955032B/xx unknown
- 1995-06-22 PE PE1995272088A patent/PE33396A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996000071A1 (fr) | 1996-01-04 |
| IL114129A0 (en) | 1995-10-31 |
| MA23588A1 (fr) | 1995-12-31 |
| ZA955032B (en) | 1996-03-11 |
| AU2703695A (en) | 1996-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE33396A1 (es) | Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar | |
| UY25374A1 (es) | Composiciones de apomorfina útiles en el tratamiento de disfunción sexual femenina | |
| CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
| SE8903914D0 (sv) | Oral composition for the treatment of inflammatory bowel diseases | |
| ATE113834T1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
| ES2167453T3 (es) | Composicion de suministro medicamentoso que contiene quitosano o derivado del mismo con un potencial z. definido. | |
| KR970704429A (ko) | 심혈관 질환의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of cardiovascular diseases) | |
| DE3851152D1 (de) | Cyclosporin-augenmittel. | |
| KR920702216A (ko) | 아세틸 d-카르니틴의 녹내장 치료에의 용도 | |
| AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
| PE68899A1 (es) | Composicion que contiene paracetamol | |
| ES2087623T3 (es) | Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon. | |
| MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
| ES2142430T3 (es) | Compuestos farmaceuticos en forma de gel conteniendo sales de sulfato de condroitina apropiadas para administracion oral. | |
| CO4960654A1 (es) | Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores | |
| BR0111325A (pt) | processo de controlar o ronco em uma pessoa, e, produto adaptado para uso no tratamento do ronco | |
| KR920702225A (ko) | 약학 조성물 | |
| ES2039433T3 (es) | Una formulacion farmaceutica. | |
| ATE81462T1 (de) | Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie. | |
| KR920014474A (ko) | 담석 붕괴용 제제 | |
| ES2092559T3 (es) | Formulacion farmaceutica que contiene penciclovir. | |
| KR880009656A (ko) | 국소 치근막 질환의 치료 또는 예방법 | |
| ES2128353T3 (es) | Composicion topica que contiene penciclovir. | |
| KR880010762A (ko) | 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers) | |
| ES2101311T3 (es) | Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |